Skip to content

Exagen Inc. XGN Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

MSCI logo
MSCIMSCI
$51.4M+78.5%
General Dynamics logo
General DynamicsGD
$58M-15.9%
Carrier Global logo
Carrier GlobalCARR
$76M-11.6%
Keysight Technologies logo
Keysight TechnologiesKEYS
$6M
L3Harris Technologies logo
L3Harris TechnologiesLHX
$43M
Duke Energy logo
Duke EnergyDUK
$1B0.0%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net?
Exagen Inc. (XGN) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $3.17M in Q1 2026.
How has Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net increased by 5186.7% year-over-year, from $60K to $3.17M.
What is the long-term trend for Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 5 years (2020 to 2025), Exagen Inc.'s debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a 62.0% compound annual growth rate (CAGR), from $296K to $3.3M.